DOR BIOPHARMA/SIGMA-TAU HOLDING AMERICA, INC. SCHEDULE 13G - 01/03/07

Company

SOLIGENIX, INC.

Filed

January 12, 2007

Accession Number

0000950162-07-000037

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →